Events down to a science
Demy-Colton events are dedicated to growing the life sciences industry and helping biopharmaceutical companies bring innovative therapies to patients as quickly and efficiently as possible. We’re committed to showcasing the best in biotech.
As one of the world's largest annual investor and partnering events with over 3.000 attendees from 52 countries, this event includes over 900+ investors and 400+ mid-/small-cap public and private presenting companies. The event features multiple tracks of presenting companies, plenary sessions, fireside chats, workshops, ample networking opportunities as well as one-on-one meetings.
Visit the Biotech Showcase 2018 website.
The convergence of digital connectivity and healthcare has already radically altered the way therapies are developed and patients receive care. At the Digital Medicine and Medtech Showcase, key opinion leaders, investors and CEOs with deep experience in the digital medicine and medtech spaces discuss the latest advances and industry trends with an eye toward how these evolving sectors can advance biopharmaceutical innovation and patient care. Discussions also delve into areas such as how financing, lifecycle, and regulatory sectors interact to impact incumbent biopharma companies.
Visit the Digital Medicine and Medtech Showcase 2018 website.
Demy-Colton's Biotech CEO Summits are closed-door, think tank-style meetings that bring together the next wave of biotech industry leaders who are united by the common goal of driving responsible growth and innovation as the industry comes of age. These invitation-only, fully interactive gatherings are limited to CEOs, and designed to engage participants in a series of dialogues that address the challenges of navigating the rapidly evolving biotech landscape. The goal of these events is to cooperatively address the challenge of finding the balance between vision and pragmatism in a critical industry that is maturing.